Live Breaking News & Updates on Vaccine Evaluation|Page 6
Stay updated with breaking news from Vaccine evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Defence Therapeutics Inc.: Defence Therapeutics Signs an Agreement with Biopharma Excellence, a Pharmalex GmbH Company, to Maximize and Strategize the Development of Its Accum Platform and Clinical Trials Defence or the Company ), a biotechnology company working on cancer therapeutics and infectious disease vaccines is pleased to announce the agreement with the German renowned pharmaceutical consulting and advisory company, Pharmalex GmbH, through Biopharma Excellence. With more than 35,000 successful projects completed, Pharmalex GmbH is a leading provider of specialized services for the pharmaceuticals, biotech and medical device industries that prioritize compliance. Biopharma Excellence, a Pharmalex GmbH division, is a leading pharmaceutical consultancy company with expertise covering all areas from development to approval and partnering of biopharmaceuticals with a focus on Europe, United States and Japan regulatory affairs. ....
DOST: WHO Solidarity Vaccine Trial, COVID-19 jab mix-and-match trial to push through amid ECQ mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
PH vaccine, health experts studying all variants of COVID-19 virus — DOST – Manila Bulletin mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
Published July 28, 2021, 12:32 PM The Department of Science and Technology’s (DOST) Vaccine Expert Panel (VEP) warned the public against interchanging coronavirus disease (COVID-19) vaccines, even as it appealed to wait for the start of the Philippines’ study on the safety and efficacy of mixing and matching five jab brands next month. (MANILA BULLETIN FILE PHOTO) VEP chairperson Dr. Nina Gloriani said they should be given more time to study the safety and immunogenicity of interchanging vaccine brands. “We are all one in all the experts group that we are not recommending interchanging vaccines until we generate local data. That’s all I can say,” she told the Manila Bulletin in a Viber message. ....
(Photo by Ali Vicoy/MANILA BULLETIN) DOST Undersecretary for Research and Development Rowena Cristina L. Guevara, who leads the Task Group on Vaccine Evaluation and Selection (TG-VES), said the Philippine Society for Allergy, Asthma, and Immunology (PSAAI) study on the safety and immunogenicity of interchanging vaccine brands has yet to start and will likely be conducted within the month of August. “The vaccination for the mix and match study is targeted to start within August once all preparations are in place and vaccine supplies allocations have been confirmed with the DOH (Department of Health),” she told the Manila Bulletin in a Viber message. ....